Announcements Trials

Browse Landscape

Phase

Phase NA 9 Phase 3 3 Phase 2 2 Phase 4 1 Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 37 Carcinoma, Non-Small-Cell Lung 29 Prostatic Neoplasms 20 Neoplasm Metastasis 19 Breast Neoplasms 19 Colorectal Neoplasms 17 Squamous Cell Carcinoma of Head and Neck 14 Leukemia, Myeloid, Acute 14 Stomach Neoplasms 12 Ovarian Neoplasms 12 Melanoma 12 Lung Neoplasms 12 Carcinoma, Hepatocellular 12 Recurrence 11 Hematologic Neoplasms 10 Endometrial Neoplasms 10 Rectal Neoplasms 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Pancreatic Neoplasms 9 Lymphoma 9 Head and Neck Neoplasms 9 Myasthenia Gravis 8 Leukemia 8 Urinary Bladder Neoplasms 7 Neoplasms by Site 7 Neoplasms by Histologic Type 7 Lymphoma, Large B-Cell, Diffuse 7 Glioblastoma 7 Fatigue 6 Colonic Neoplasms 6

Interventions

saxagliptin 1 dapagliflozin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Diabetes Mellitus, Type 2 × 1 year × Clear all

NCT07033585 2025-07-11

GD-T2D

Medicine Invention Design, Inc

Phase 2/3 Active not recruiting

Diabetes Mellitus, Diabetes Mellitus, Type 2

Data powered by HemOnc (CC BY 4.0) Colophon ⚡